Zepbound (tirzepatide) is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off.

Media members may access multimedia resources such as fact sheets, infographics, photos, logos, select press releases and more, all for use in stories in development. Zepbound® (tirzepatide)

The following 25 images provide visual information about the product associated with Zepbound NDC 0002-0152 by Eli Lilly And Company, such as packaging, labeling, and the appearance of the drug itself.

Zepbound® is a prescription weight loss medication designed to aid in weight management through a specific mechanism of action. As a GLP-1 receptor agonist, it mimics a hormone your body naturally produces to regulate hunger and stabilize blood sugar levels.

Check out our zepbound logo selection for the very best in unique or custom, handmade pieces from our prints shops.

View images of Zepbound and identify pills by imprint code, shape and color with the Drugs.com Pill Identifier.

Zepbound 2.5 and 5 mg vials are available exclusively through LillyDirect's self-pay pharmacy channel for patients with a prescription from their healthcare provider.

ZEPBOUND is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults.

Dec 5, 2023 · (CNN) — Drug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is now available for patient use. Tirzepatide, its active ingredient, had been approved by the US Food and Drug Administration as a …

Jan 4, 2025 · Zepbound is a prescription weight loss medication that has gained FDA approval for its ability to aid individuals in achieving sustainable weight loss. It is primarily recommended for certain individuals struggling with obesity or those who are overweight and have weight-related health conditions.